Campomanes, Angelly R.

HRN: 10-53-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
CEFUROXIME 1.5GM (VIAL)
06/22/2022
06/29/2022
IV
1.5gm
Q8
Incomplete Abortion Nonseptic.noninduced Leukocytosis 25.8
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: